ProfCatherine Greene

Associate Professor

Clinical Microbiology

  • Associate Professor
    Clinical Microbiology
  • 01 8093712 (Work)
  • RCSI, Clinical Microbiology, First Floor, ERC II, Smurfit Building, Beaumont Hospital, Dublin, 9, Ireland

IMPACT AND ENGAGEMENT OVERVIEW

Impact and Engagement Overview

 

Prof Greene’s work has advanced understanding of how non-coding RNAs shape lung health and disease, trained a generation of researchers, and strengthened RCSI’s international research partnerships.

 

Scientific Impact: A leading contributor to the field of microRNA biology in the lung, with more than 190 peer-reviewed publications and a Scopus h-index of 59. Her research has defined how miRNAs regulate innate immunity, inflammation and host–pathogen interactions in cystic fibrosis, alpha-1 antitrypsin deficiency and COPD. She developed the MiR-CATCH methodology for identifying miRNA targets.

 

Clinical Impact: Joint senior author of a landmark New England Journal of Medicine study showing that oestrogen promotes Pseudomonas mucoidy and exacerbations in women with CF. This helped explain why female patients fare worse, and it continues to inform research into sex differences in lung disease.

 

Translational Impact: Her group is developing inhaled, nucleotide-based therapeutics. They are also pioneering a new antimicrobial strategy that uses human miRNAs, delivered by DNA-tetrahedron nanostructures, to target CF and ESKAPE pathogens, addressing the global challenge of antimicrobial resistance.

 

Education and Training Impact: As Deputy Head of the School of Postgraduate Studies with responsibility for PhD Programmes, she leads doctoral education across RCSI. This includes the international RCSI–Soochow University StAR PhD Programme and the RCSI–University of Pittsburgh Dual PhD in Precision and Regenerative Medicine. She has supervised 23 research students to completion and examined 25 PhD candidates.

 

Leadership in the Discipline: She is co-Editor-in-Chief of the Journal of Innate Immunity. She was Head of European Respiratory Society Assembly 3 (Basic and Translational Science) from 2019 to 2022 and became an ERS Fellow in 2021. She has served on review panels for the European Commission and international funders.

 

Societal and Ethical Impact: A strong advocate for human-relevant, non-animal research models in respiratory science, including through work with the European Commission’s Joint Research Centre highlighting advanced non-animal models of lung disease.